Breaking News Instant updates and real-time market news.

ALKS

Alkermes

$57.93

0.71 (1.24%)

04:55
05/19/17
05/19
04:55
05/19/17
04:55

Alkermes management to meet with JPMorgan

Meeting to be held in Los Angeles on May 19 hosted by JPMorgan.

  • 19

    May

  • 06

    Jun

  • 08

    Jun

ALKS Alkermes
$57.93

0.71 (1.24%)

04/27/17
JEFF
04/27/17
NO CHANGE
Target $69
JEFF
Buy
Jefferies trims Alkermes target to $69 after Q1 miss
Jefferies analyst Biren Amin attributes Alkermes' Q1 miss to Vivitrol and lowered his price target for the shares to $69 from $70. The analyst keeps a Buy rating on the name. Management blamed inventory destocking for the weaker than expected Vivitrol sales and reiterated the drug's outlook for 2017, Amin tells investors in a post-earnings research note. He expects the challenges Aristada observed from higher gross to net rebates in the quarter to stabilize in the second half of 2017.
04/27/17
JPMS
04/27/17
NO CHANGE
Target $78
JPMS
Overweight
JPMorgan keeps Overweight rating on Alkermes after Q1 miss
JPMorgan analyst Cory Kasimov attributes Alkermes' Q1 miss to "commercial seasonality and pricing." He points out management reiterated 2017 guidance and highlighted that underlying trends for both Aristada and Vivitrol remain strong. The analyst continues to believe the legacy base business, combined with the growth potential of Vivitrol and Aristada and the optionality of the wholly owned late-stage pipeline, offers an "attractive combo" for investors. Kasimov keeps an Overweight rating on Alkermes with a $78 price target.
05/01/17
FBCO
05/01/17
NO CHANGE
Target $70
FBCO
Outperform
Alkermes price target lowered to $70 from $78 at Credit Suisse
Credit Suisse analyst Vamil Divan lowered his price target for Alkermes to $78 from $70 after Q1 results. The analyst reiterates an Outperform rating, and notes that his enthusiasm on Alkermes remains driven by the upside he expects from Vivitrol in the near to mid-term and then the pipeline over time.
05/18/17
LEER
05/18/17
NO CHANGE
LEER
Outperform
Leerink sees 'multiple approvability questions' for Alkermes in depression
Leerink analyst Paul Matteis believes "multiple approvability questions" remain after Alkermes this morning presented additional clinical data for ALKS 5461 in treatment resistant depression. The FDA's acceptance of a novel trial design and tweaked clinical endpoint are among the outstanding issues, Matteis tells investors in a research note. Today's data are unlikely to "materially shift the debate in the short term," the analyst adds. Matteis, however, remains "encouraged by the breadth of precedent for FDA flexibility in psychiatry" ahead of an ALKS 5461 new drug application filing in the second half of the year. He reiterates an Outperform rating on Alkermes. The stock in afternoon trading is up 57c to $57.79.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

, WFM

Whole Foods

$41.71

-0.05 (-0.12%)

06:35
07/24/17
07/24
06:35
07/24/17
06:35
Periodicals
Democrats in Congress urge review of Amazon's Whole Foods deal, Reuters says »

A group of Democrats in…

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

WFM

Whole Foods

$41.71

-0.05 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PPG

PPG

$106.37

-0.35 (-0.33%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXAS

Abraxas Petroleum

$1.61

-0.04 (-2.42%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Initiation
Abraxas Petroleum initiated  »

Abraxas Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

CALM

Cal-Maine Foods

$37.10

1 (2.77%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Earnings
Cal-Maine Foods reports Q4 EPS (51c) with items, consensus (25c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

SGMS

Scientific Games

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Earnings
Scientific Games reports Q2 EPS (44c), consensus (52c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HAS

Hasbro

$115.95

1.05 (0.91%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Hot Stocks
Hasbro CEO says entered 2H with 'strong consumer momentum' »

"The Hasbro team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

HAS

Hasbro

$115.95

1.05 (0.91%)

06:31
07/24/17
07/24
06:31
07/24/17
06:31
Hot Stocks
Hasbro CFO says seeing 'some softness' in Brazil, U.K. »

"Our balance sheet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

ALRN

Aileron Therapeutics

$12.78

-0.14 (-1.08%)

06:31
07/24/17
07/24
06:31
07/24/17
06:31
Initiation
Aileron Therapeutics initiated  »

Aileron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRX

Catalyst Pharmaceuticals

$2.95

-0.1 (-3.28%)

06:30
07/24/17
07/24
06:30
07/24/17
06:30
Conference/Events
Catalyst Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

HAS

Hasbro

$115.95

1.05 (0.91%)

06:30
07/24/17
07/24
06:30
07/24/17
06:30
Earnings
Hasbro reports Q2 EPS 53c, consensus 46c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

VLO

Valero

$67.78

0.26 (0.39%)

, PSX

Phillips 66

$82.85

0.49 (0.59%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Periodicals
U.S. mulls financial sanctions on Venezuela's PDVSA, Reuters reports »

The Trump administration…

VLO

Valero

$67.78

0.26 (0.39%)

PSX

Phillips 66

$82.85

0.49 (0.59%)

CVX

Chevron

$103.25

-1.38 (-1.32%)

PBF

PBF Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 28

    Jul

  • 01

    Aug

  • 03

    Aug

KCDMY

Kimberly-Clark de Mexico

$10.34

-0.3 (-2.82%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Upgrade
Kimberly-Clark de Mexico rating change  »

Kimberly-Clark de Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$106.37

-0.35 (-0.33%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Downgrade
PPG rating change  »

PPG downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FND

Floor & Decor

$37.40

-1.1 (-2.86%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Upgrade
Floor & Decor rating change  »

Floor & Decor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BABA

Alibaba

$151.89

-0.22 (-0.14%)

, MGI

MoneyGram

$16.56

-0.28 (-1.66%)

06:26
07/24/17
07/24
06:26
07/24/17
06:26
Periodicals
Smith says U.S. should block Ant, MoneyGram deal, NY Post reports »

Rep. Chris Smith, the…

BABA

Alibaba

$151.89

-0.22 (-0.14%)

MGI

MoneyGram

$16.56

-0.28 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTZ

MasTec

$45.30

-0.35 (-0.77%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Upgrade
MasTec rating change  »

MasTec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Aug

WFC

Wells Fargo

$54.17

-0.71 (-1.29%)

06:23
07/24/17
07/24
06:23
07/24/17
06:23
Hot Stocks
Wells Fargo ordered to reinstate whistleblower, pay $577K in back wages, damages »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 15

    Jan

MIK

Michaels

$19.02

0.22 (1.17%)

06:23
07/24/17
07/24
06:23
07/24/17
06:23
Upgrade
Michaels rating change  »

Michaels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$66.00

-0.36 (-0.54%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Conference/Events
Citi to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SFTBF

SoftBank

$82.90

-0.25 (-0.30%)

06:20
07/24/17
07/24
06:20
07/24/17
06:20
Periodicals
Didi Chuxing, SoftBank to invest $2B in ride-hail startup Grab, Recode says »

Chinese ride-hailing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHF

Brighthouse Financial

, MET

MetLife

$54.65

0.07 (0.13%)

06:20
07/24/17
07/24
06:20
07/24/17
06:20
Initiation
Brighthouse Financial, MetLife initiated  »

Brighthouse Financial…

BHF

Brighthouse Financial

MET

MetLife

$54.65

0.07 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 14

    Aug

  • 15

    Aug

ACM

Aecom

$32.02

-0.25 (-0.77%)

06:19
07/24/17
07/24
06:19
07/24/17
06:19
Downgrade
Aecom rating change  »

Aecom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TEVA

Teva

$32.64

0.21 (0.65%)

06:18
07/24/17
07/24
06:18
07/24/17
06:18
Periodicals
Teva to cut Israeli workforce, mainly in production, Reuters reports »

Teva is planning to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 30

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.